Terminology Service for NFDI4Health

Ramucirumab/Docetaxel Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C136285


A chemoimmunotherapy regimen consisting of ramucirumab and docetaxel that is used for the treatment of non-small cell lung cancer (NSCLC). [ ]

Term info

Label

Ramucirumab/Docetaxel Regimen

Synonyms
  • Cyramza/Docetaxel Regimen
  • Ramucirumab-Docetaxel
  • Ramucirumab-Docetaxel Regimen
  • Ramucirumab/Docetaxel
  • Ramucirumab/Docetaxel Regimen
Subsets

NCIT_C160952, NCIT_C160950

NCI META CUI

CL523596

Preferred Name

Ramucirumab/Docetaxel Regimen

Semantic Type

Therapeutic or Preventive Procedure

code

C136285